Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Ludovica Iovino, Veronica Giusti, Francesca Pischedda, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 1, pp. 81-106
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders
Ashley N. Brandebura, Adrien Paumier, Tarik Seref Onur, et al.
Nature reviews. Neuroscience (2022) Vol. 24, Iss. 1, pp. 23-39
Open Access | Times Cited: 253
Astrocytes in human central nervous system diseases: a frontier for new therapies
Alexei Verkhratsky, Arthur M. Butt, Baoman Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 150
Brain clearance of protein aggregates: a close-up on astrocytes
Veronica Giusti, G Kaur, Elena Giusto, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 19
Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
Amica Corda Müller-Nedebock, Marieke C. J. Dekker, Matthew J. Farrer, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Role of Astrocytes in Parkinson’s Disease Associated with Genetic Mutations and Neurotoxicants
Sang Hoon Kim, Edward Pajarillo, Ivan Nyarko‐Danquah, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 622-622
Open Access | Times Cited: 27
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
Jiarui Hu, Dan Zhang, Keyue Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115475-115475
Closed Access | Times Cited: 26
Astrocytes: The Stars in Neurodegeneration?
Katarina Stoklund Dittlau, Kristine Freude
Biomolecules (2024) Vol. 14, Iss. 3, pp. 289-289
Open Access | Times Cited: 13
A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases
Igor C. Fontana, Débora Guerini de Souza, Diogo O. Souza, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2330-2346
Open Access | Times Cited: 21
Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer’s disease progression
Daniele Lana, Filippo Ugolini, Ludovica Iovino, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 18
Open Access
Remote Regulation of Molecular Diffusion in Extracellular Space of PD Rat Model by STN-DBS
Dan Du, Wanyi Fu, Shaoyi Su, et al.
Cyborg and Bionic Systems (2025) Vol. 6
Open Access
Common alterations to astrocytes across neurodegenerative disorders
Aksinya Derevyanko, Tao Tao, Nicola J. Allen
Current Opinion in Neurobiology (2025) Vol. 90, pp. 102970-102970
Closed Access
Role of dopaminergic RE1-silencing transcription factor (REST) in manganese-induced behavioral deficits and dysregulating dopaminergic and serotonergic neurotransmission in mice
Sang Hoon Kim, Edward Pajarillo, Alexis Digman, et al.
NeuroToxicology (2025)
Closed Access
From postsynaptic neurons to astrocytes: the link between glutamate metabolism, Alzheimer’s disease and Parkinson’s disease
Fu-Wang Liu, X. Zhang, Yi-Fan Cong, et al.
Reviews in the Neurosciences (2025)
Closed Access
Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice
Daniela Mercatelli, Alberto Brugnoli, Anna Maio, et al.
Neurobiology of Disease (2025), pp. 106881-106881
Open Access
The “www” of Xenopus laevis Oocytes: The Why, When, What of Xenopus laevis Oocytes in Membrane Transporters Research
Manan Bhatt, Angela Di Iacovo, Tiziana Romanazzi, et al.
Membranes (2022) Vol. 12, Iss. 10, pp. 927-927
Open Access | Times Cited: 16
Astrocytes in Parkinson’s Disease: From Role to Possible Intervention
Tianyou Wang, Yingqi Sun, Ulf Dettmer
Cells (2023) Vol. 12, Iss. 19, pp. 2336-2336
Open Access | Times Cited: 10
LRK-1/LRRK2 and AP-3 regulate trafficking of synaptic vesicle precursors through active zone protein SYD-2/Liprin-α
Sravanthi S. P. Nadiminti, Shirley B. Dixit, Neena Ratnakaran, et al.
PLoS Genetics (2024) Vol. 20, Iss. 5, pp. e1011253-e1011253
Open Access | Times Cited: 3
Astroglial membrane camouflaged Ptbp1 siRNA delivery hinders glutamate homeostasis via SDH/Nrf2 pathway
Yan Liu, Jian Ren, Wenlong Zhang, et al.
Biomaterials (2024) Vol. 312, pp. 122707-122707
Closed Access | Times Cited: 3
Neurodegenerative diseases
Alexei Verkhratsky, Arthur M. Butt
Neuroglia (2023), pp. 563-598
Open Access | Times Cited: 8
PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner
Lucia Iannotta, Rachel Fasiczka, Giulia Favetta, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 2
Modeling Parkinson’s disease in LRRK2 rodents
Chiara Domenicale, Stefano Magnabosco, Michele Morari
Neuronal Signaling (2023) Vol. 7, Iss. 3
Open Access | Times Cited: 5
Insights into the cellular consequences of LRRK2-mediated Rab protein phosphorylation
Rachel Fasiczka, Yahaira Naaldijk, Besma Brahmia, et al.
Biochemical Society Transactions (2023) Vol. 51, Iss. 2, pp. 587-595
Open Access | Times Cited: 4
Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson’s disease and advanced therapeutic strategies
Ajmal Nassar, Triveni Kodi, Sairaj Satarker, et al.
Gene (2023) Vol. 892, pp. 147898-147898
Open Access | Times Cited: 4
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery
Eoin C. O’Connor, Kumiko Kambara, Daniel Bertrand
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 2, pp. 173-187
Open Access | Times Cited: 4
Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease
Ludovica Iovino, J. VanderZwaag, G Kaur, et al.
Neurobiology of Disease (2024) Vol. 195, pp. 106481-106481
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top